Садковое выращивание осетровых рыб в мелиоративном водоеме Припятского Полесья с использованием в кормах суспензии хлореллы

Выращивание осетровых рыб в садках с использованием в качестве добавки к кормам суспензии хлореллы показало, что добавление в кормовую смесь 10 % суспензии хлореллы от рассчитываемой массы корма обеспечивало увеличение средней массы стерляди и ленского осетра на 19,9 и 25,1 % соответственно. Такая технология позволяла экономить в день до 4,3 € из затрачиваемых 57 € на кормление рыбы. Она пригодна для использования как в индустриальных, так и фермерских рыбоводных хозяйствах. Growing of sturgeon in cages, using as feed supplements Chlorella suspension, showed that the addition to the feed mixture of 10% suspension of chlorella on the mass of the food provided to increasethe average weight of Sterlet and Lena sturgeon by 19,9 and 25,1% respectively. This technology saves up 4,3 € of the 57€ spent on feeding the fish per day. It is suitable for use in industrial and farming aquaculture

Тактика ведения пациентов с псевдомиксомой брюшины при продолженном росте опухоли. Клиническое наблюдение

Pseudomixoma peritonei is a rare type of peritoneal carcinomatosis demonstrating an indolent course and a high rate of recurrence. primary surgical interventions in patients with pseudomixoma peritonei are extensive and traumatic, which worsens the chances for performing re-operation and may increase the rate of postoperative complications. above mentioned circumstances forms a problem in the choice of management for patients with recurrent pseudomyxoma peritonei. in this article we present a clinical case of successful treatment of recurrent disease.Сlinical case. The 62 years female patient in 2006 first noticed pain in the lower abdomen. the examination revealed a tumor near the right appendages. on 28.12.2006 the uterus was extirpated with appendages, appendectomy, resection of the large omentum; 6 courses of chemotherapy (cap) were conducted. in may 2007 and June 2009, repeated cytoreductive operations were performed with subsequent 12 courses of chemotherapy. in 2012 a patient with a relapse of the disease was re-operated at the N.N. Blokhin NmRcof oncology. Re-operation was performed in the volume of removal of bulk of the tumor in the right and left sub-diaphragmatic spaces with resection of both domes of the diaphragm, splenectomy, removal of the remaining part of the large omentum, with subsequent hyperthermic intraperitoneal chemoperfusion with cisplatin. complications were not noted. after 14 months, ctand ultrasound revealed progression of the disease. in 2013 an attempt was made to re-surgical intervention. during re-operation in the abdominal cavity a massive adhesive process was found. given the palliative nature of the intervention and the high risk of progression, the volume of surgery is limited to a biopsy of the tumor mass. later 4 courses of chemotherapy were conducted. during period of follow-up, relapse of tumor was noted with the development of partial small intestinal obstruction, which did not require emergency intervention. at present, 26 months after the combined treatment, the patient’s condition is satisfactory, with no signs of intestinal obstruction.Сonclusion. Performance repeated surgical interventions for pseudomixoma peritonei is a rather difficult task for, due to the fact that with continued growth, it is more difficult to achieve optimal cytoreduction. the basic condition for re-operation should be referred to the initial optimal level of cytoreduction and a long-term disease-free period.Псевдомиксома брюшины представляет собой редкую разновидность перитонеального канцероматоза, обладает медленным ростом и высокой частотой рецидивирования. Первичные хирургические вмешательства у больных с псевдомиксомой брюшины отличаются большим объемом и травматичностью, что ухудшает условия выполнения повторных операций и может повышать риск послеоперационных осложнений. Все перечисленное формирует проблему в выборе тактики лечения пациентов с рецидивной псевдомиксомой.Описание клинического случая. Пациентка 62 лет в ноябре 2006 г. впервые отметила появление болей внизу живота. При обследовании выявлена опухоль в проекции правых придатков. По месту жительства 28.12.06 выполнена экстирпация матки с придатками, аппендэктомия, резекция большого сальника; проведено 6 курсов химиотерапии (cap). В мае 2007 г. и июне 2009 г. проводились повторные циторедуктивные операции, 12 курсов полихимиотерапии. В 2012 г. в связи с рецидивом заболевания в НМИЦ онкологии им. Н.Н. Блохина выполнено комбинированное лечение: циторедуктивная операция в объеме удаления опухолевых узлов в правом и левом поддиафрагмальных пространствах с резекцией обоих куполов диафрагмы, спленэктомией, удалением оставшейся части большого сальника, а также гипертермическая интраперитонеальная химиоперфузия цисплатина. Непосредственных осложнений не отмечено. Через 14 мес при КТ и УЗИ выявлено прогрессирование. В 2013 г. была проведена попытка повторного хирургического вмешательства, при ревизии в брюшной полости обнаружен массивный спаечный процесс. Учитывая паллиативный характер вмешательства и высокий риск прогрессирования, объем операции ограничен биопсией опухоли. В дальнейшем было проведено 4 курса химиотерапии. На фоне лечения отмечен продолженный рост опухолевых узлов по брюшине с развитием частичной тонкокишечной непроходимости, которая не требовала экстренного вмешательства. В настоящее время, через 26 мес после комбинированного лечения, состояние пациентки удовлетворительное, без признаков кишечной непроходимости.Заключение. Выполнение повторных хирургических вмешательств при псевдомиксоме представляет собой достаточно сложную задачу в связи с тем, что при продолженном росте сложнее добиться оптимальной циторедукции. К основным условиям к повторному хирургическому вмешательству следует отнести исходный оптимальный уровень циторедукции и длительный безрецидивный период

Вакцинопрофилактика пневмококковой инфекции у детей

Pneumococcal infection remains one of the leading reasons for infant mortality from vaccine-preventable infections. Today vaccination is the most effective way to prevent diseases caused by antibiotic-resistant pneumococci. In the article, authors present current approaches to vaccinal prevention of pneumococcal diseases. The plan of action for carrying out active immunoprophylaxis of pneumococcal infection is explained in detail for both healthy children and patients from risk groups for severe pneumococcal diseases development. The published work is based on key points of the guidelines of the Ministry of Health of the Russian Federation on vaccinal prevention of pneumococcal infection (developed and approved by the professional association of pediatricians «The Union of Pediatricians of Russia»).Пневмококковая инфекция остается одной из ведущих причин детской смертности от вакциноуправляемых инфекций. Вакцинация на сегодняшний день является наиболее эффективным направлением профилактики заболеваний, вызываемых устойчивыми к антибактериальным препаратам пневмококкам. В статье коллективом авторов представлены актуальные подходы к вакцинопрофилактике болезней пневмококковой этиологии. Подробно разъяснен алгоритм действий при проведении активной иммунопрофилактики пневмококковой инфекции как здоровых детей, так и пациентов из групп риска по развитию тяжелых форм пневмококковых заболеваний. Публикация основана на ключевых позициях методических рекомендаций Министерства здравоохранения РФ по вакцинопрофилактике пневмококковой инфекции (разработанных и утвержденных профессиональной ассоциацией детских врачей «Союз педиатров России»).КОНФЛИКТ ИНТЕРЕСОВАвторы статьи подтвердили отсутствие конфликта интересов, о котором необходимо сообщить

CHALLENGES IN CHOICE OF THE TREATMENT STRATEGY FOR PATIENTS WITH RECURRENT PSEUDOMYXOMA PERITONEI

Pseudomixoma peritonei is a rare type of peritoneal carcinomatosis accompanied by accumulation of mucus and high recurrence rate and in some cases complicated with intestinal obstruction. In the last 10–15 years, there has been observed a significant improvement in overall survival of patients with recurrent pseudomyxoma, who underwent cytoreductive surgery in combination with intraperitoneal chemotherapy. However, the frequency of recurrences of peritoneal pseudomyxoma after optimal cytoreduction can reach 80–90 % in the first 2 years.The purpose of the study was to analyze the results of combined therapy (cytoreductive surgery and hypothermic intraperitoneal chemoperfusion) in patients with recurrent pseudomyxoma peritonei, who previously underwent cytoreductive surgery.Material and Methods. The study included 43 patients previously undergoing cytoreductive surgery for pseudomyxoma peritonei in the Thoracic Oncology Department of the N.N. Blokhin National Medical Research Center of Oncology.Results. Re-operations were performed in 11 of the 43 patients with recurrent pseudomixoma peritonei after previously performed cytoreductive surgery. Repeated intraperitoneal chemoperfusion with hyperthermia was performed in 6 patients. Of the 11 reoperated patients, 7 had a complete cytoreduction (CC-0), recurrence was detected within 22 to 47 months; 2 patients had CC-1 and recurrence was observed within 12 and 15 months. Optimal cytoreduction (CC0-1) was achieved in 7 of the 11 patients. The maximum follow-up period was 44 months. Recurrence was noted in 9 patients, while the majority of patients had a satisfactory quality of life. Two patients showed signs of partial intestinal obstruction. None of the patients died during the follow-up period. In two patients with optimal (CC-0) cytoreduction, there were no signs of disease progression 9 and 15 months after re-surgery. One-year disease-free survival rate was 51 %.Conclusion. Repeated surgeries for recurrent pseudomyxoma present a great challenge for surgeons due to the difficulty in achieving optimal cytoreduction. Optimal cytoreduction in initial surgery should be considered as the main condition for repeated surgery. Moreover, additional criterion for a favorable prognosis is the time to progression of disease

Challenges in choice of the treatment strategy for patients with recurrent pseudomyxoma peritonei

Pseudomixoma peritonei is a rare type of peritoneal carcinomatosis demonstrating an indolent course and a high rate of recurrence. primary surgical interventions in patients with pseudomixoma peritonei are extensive and traumatic, which worsens the chances for performing re-operation and may increase the rate of postoperative complications. above mentioned circumstances forms a problem in the choice of management for patients with recurrent pseudomyxoma peritonei. in this article we present a clinical case of successful treatment of recurrent disease.Сlinical case. The 62 years female patient in 2006 first noticed pain in the lower abdomen. the examination revealed a tumor near the right appendages. on 28.12.2006 the uterus was extirpated with appendages, appendectomy, resection of the large omentum; 6 courses of chemotherapy (cap) were conducted. in may 2007 and June 2009, repeated cytoreductive operations were performed with subsequent 12 courses of chemotherapy. in 2012 a patient with a relapse of the disease was re-operated at the N.N. Blokhin NmRcof oncology. Re-operation was performed in the volume of removal of bulk of the tumor in the right and left sub-diaphragmatic spaces with resection of both domes of the diaphragm, splenectomy, removal of the remaining part of the large omentum, with subsequent hyperthermic intraperitoneal chemoperfusion with cisplatin. complications were not noted. after 14 months, ctand ultrasound revealed progression of the disease. in 2013 an attempt was made to re-surgical intervention. during re-operation in the abdominal cavity a massive adhesive process was found. given the palliative nature of the intervention and the high risk of progression, the volume of surgery is limited to a biopsy of the tumor mass. later 4 courses of chemotherapy were conducted. during period of follow-up, relapse of tumor was noted with the development of partial small intestinal obstruction, which did not require emergency intervention. at present, 26 months after the combined treatment, the patient’s condition is satisfactory, with no signs of intestinal obstruction.Сonclusion. Performance repeated surgical interventions for pseudomixoma peritonei is a rather difficult task for, due to the fact that with continued growth, it is more difficult to achieve optimal cytoreduction. the basic condition for re-operation should be referred to the initial optimal level of cytoreduction and a long-term disease-free period

Cage Growing of Sturgeon in the Reclamation Ponds of Pripyat Polesie using as Feed Supplements Chlorella Suspension

Выращивание осетровых рыб в садках с использованием в качестве добавки к кормам суспензии хлореллы показало, что добавление в кормовую смесь 10 % суспензии хлореллы от рассчитываемой массы корма обеспечивало увеличение средней массы стерляди и ленского осетра на 19,9 и 25,1 % соответственно. Такая технология позволяла экономить в день до 4,3 € из затрачиваемых 57 € на кормление рыбы. Она пригодна для использования как в индустриальных, так и фермерских рыбоводных хозяйствах.Growing of sturgeon in cages, using as feed supplements Chlorella suspension, showed that the addition to the feed mixture of 10% suspension of chlorella on the mass of the food provided to increasethe average weight of Sterlet and Lena sturgeon by 19,9 and 25,1% respectively. This technology saves up 4,3 € of the 57€ spent on feeding the fish per day. It is suitable for use in industrial and farming aquaculture

Vaccine Prevention of Pneumococcal Infection in Children

Pneumococcal infection remains one of the leading reasons for infant mortality from vaccine-preventable infections. Today vaccination is the most effective way to prevent diseases caused by antibiotic-resistant pneumococci. In the article, authors present current approaches to vaccinal prevention of pneumococcal diseases. The plan of action for carrying out active immunoprophylaxis of pneumococcal infection is explained in detail for both healthy children and patients from risk groups for severe pneumococcal diseases development. The published work is based on key points of the guidelines of the Ministry of Health of the Russian Federation on vaccinal prevention of pneumococcal infection (developed and approved by the professional association of pediatricians «The Union of Pediatricians of Russia»)